When evaluating your options, consider asking: How many patients have they treated with GLP-1 medications
[DOI] [PubMed] [Google Scholar] 264.Mingrone G, Panunzi S, De Gaetano A, et al
#AutoimmuneDiseases #Immunology #PrecisionMedicine #Biotech #Pharma #PharmaDeals #LifeSciences #Biopharma To view or add a comment, sign in # GLP-1 + anti-GIPR antibody conjugate In the last 14 days, #WIPO published a patent application (WO2025199030) on a novel #ADC consisting a #GLP-1 receptor agonist and an anti-GIPR (gastric inhibitory peptide receptor) antibody
Frequently Asked Questions FOXO4-DRI is used in laboratory studies investigating cellular senescence, apoptosis signaling, and FOXO4p53 interaction pathways
doi: 10.1016/j.jacc.2005.02.053
This analysis revealed that the long-lived glp-1(-) and fem-3(-) mutants cluster more closely with each than with mog-3(-) mutants (Supplementary Fig